| Effects of metabolic regulation, diabetes age and lipids on the development of diabetic retinopathy in type 2 diabetes mellitus | Eşref M. ÖZER, Hüsamettin KUTLU, Meltem AYTER, Ayla KUT, Kazım TURAN | 150–154 |
| Comparison of the anti proteinuric effects of angiotensin II receptor blocer losartan and angiotensin converting enzyme inhibitor enalapril in proteinuria in patients with diabetic nephropathy | Ali Rıza ODABAŞ, Yılmaz SELÇUK, İlyas ÇAPOĞLU, Ramazan ÇETİNKAYA, Necdet ÜNÜVAR | 155–158 |
| A single center randomized study comparing the efficacy of ACE inhibitors and pentoxifylline VS ACE inhibitor alone on microalbuminuria in type 2 hypertensive diabetic patients | Selçuk ŞEBER, Ahmet ŞENGÜL, Güler TÜRKEŞ, Sema UÇAK, Taner BAŞTÜRK, Yüksel ALTUNTAŞ | 159–160 |
| Is it necessary to measure the daily magnesium excretion in type II diabetic patients? | Nuri HAKSEVER, Hayati TOR, Muammer GÖZAYDIN, Muzaffer SEZER | 161–164 |
| Latex sensitivity in type 1 diabetes mellitus | Göksal KESKİN, Murat SUHER, E. Dilek KESKİN, Faruk KALKAN, Ali İNAL | 169–170 |
| General assessment of our diabetic patients who treated in our in-patient clinic | Emir DÖNDER, Halil DOĞAN, Yusuf ÖZKAN, Mehmet YALNIZ, Yılmaz ÖZBAY, Şerife ERDOĞAN | 171–173 |
| Gebelikte hipoparatiroidizm: Calcitriol tedavisinin fetal riskleri olabilir mi? | Rasim ÇOLAK, Fahri BAYRAM, Kürşad ÜNLÜHIZARCI, Selim KURTOĞLU, Fahrettin KELEŞTİMUR, Mustafa ÇALIK | 174–175 |
| The effects of therapy on endocrine dysfunctions in hereditary hemochromatosis: A case report | Teoman YANMAZ, Tevfik SABUNCU, Abdullah ULUÇAY, Yaşar NAZLIGÜL | 176–179 |
| Ectopic CRH secretion in pheochromocytoma: A case report | Cavit CULHA, Serdar GÜLER, Berrin DEMİRBAŞ, Rüştü SERTER, Yalçın ARAL, Feridun KARAKURT, İbrahim ŞAHİN | 180–186 |